Nothing Special   »   [go: up one dir, main page]

NO20044898L - Nye etonogestrel estere - Google Patents

Nye etonogestrel estere

Info

Publication number
NO20044898L
NO20044898L NO20044898A NO20044898A NO20044898L NO 20044898 L NO20044898 L NO 20044898L NO 20044898 A NO20044898 A NO 20044898A NO 20044898 A NO20044898 A NO 20044898A NO 20044898 L NO20044898 L NO 20044898L
Authority
NO
Norway
Prior art keywords
new
etonogestrel esters
esters
new etonogestrel
present
Prior art date
Application number
NO20044898A
Other languages
English (en)
Inventor
Henrik De Nijs
Hendrikus Adrianus Anton Voort
Dirk Leysen
Arij Jan Grootenhuis
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20044898L publication Critical patent/NO20044898L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer nye progestogen-estere og anvendelser derav.
NO20044898A 2002-05-30 2004-11-10 Nye etonogestrel estere NO20044898L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077119 2002-05-30
PCT/EP2003/050187 WO2003102012A2 (en) 2002-05-30 2003-05-22 New etonogestrel esters

Publications (1)

Publication Number Publication Date
NO20044898L true NO20044898L (no) 2005-02-25

Family

ID=29595014

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044898A NO20044898L (no) 2002-05-30 2004-11-10 Nye etonogestrel estere

Country Status (31)

Country Link
US (1) US7323454B2 (no)
EP (1) EP1513861B1 (no)
JP (1) JP4716726B2 (no)
KR (1) KR20050009723A (no)
CN (2) CN101100480A (no)
AR (1) AR040130A1 (no)
AT (1) ATE349458T1 (no)
AU (1) AU2003238081B2 (no)
BR (1) BR0311254A (no)
CA (1) CA2487722C (no)
CO (1) CO5631449A2 (no)
DE (1) DE60310714T2 (no)
DK (1) DK1513861T3 (no)
ES (1) ES2277085T3 (no)
HK (1) HK1072609A1 (no)
HR (1) HRP20041101A2 (no)
IL (1) IL165087A0 (no)
IS (1) IS2421B (no)
MX (1) MXPA04011797A (no)
NO (1) NO20044898L (no)
NZ (1) NZ536619A (no)
PE (1) PE20040068A1 (no)
PL (1) PL373855A1 (no)
PT (1) PT1513861E (no)
RS (1) RS97604A (no)
RU (1) RU2325910C2 (no)
SI (1) SI1513861T1 (no)
TW (1) TW200403065A (no)
UA (1) UA80126C2 (no)
WO (1) WO2003102012A2 (no)
ZA (1) ZA200410410B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
AU2006270221B2 (en) 2005-07-15 2012-01-19 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
US20090062909A1 (en) 2005-07-15 2009-03-05 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
AU2007243268B2 (en) 2006-04-26 2013-06-13 Micell Technologies, Inc. Coatings containing multiple drugs
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
JP5603598B2 (ja) 2007-01-08 2014-10-08 ミセル テクノロジーズ、インコーポレイテッド 生物分解層を有するステント
CN102083397B (zh) 2008-04-17 2013-12-25 米歇尔技术公司 具有生物可吸收层的支架
WO2011009096A1 (en) 2009-07-16 2011-01-20 Micell Technologies, Inc. Drug delivery medical device
CA2730995C (en) 2008-07-17 2016-11-22 Micell Technologies, Inc. Drug delivery medical device
CA2756386C (en) 2009-03-23 2019-01-15 Micell Technologies, Inc. Drug delivery medical device
JP2012522589A (ja) 2009-04-01 2012-09-27 ミシェル テクノロジーズ，インコーポレイテッド 被覆ステント
WO2010121187A2 (en) 2009-04-17 2010-10-21 Micell Techologies, Inc. Stents having controlled elution
WO2011097103A1 (en) 2010-02-02 2011-08-11 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
US10232092B2 (en) 2010-04-22 2019-03-19 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
WO2012009684A2 (en) 2010-07-16 2012-01-19 Micell Technologies, Inc. Drug delivery medical device
WO2013012689A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
CA2905419C (en) 2013-03-12 2020-04-28 Micell Technologies, Inc. Bioabsorbable biomedical implants
KR102079613B1 (ko) 2013-05-15 2020-02-20 미셀 테크놀로지즈, 인코포레이티드 생흡수성 생체의학적 임플란트
RU2595818C1 (ru) * 2015-05-25 2016-08-27 Федеральное государственное бюджетное научное учреждение "Научный центр проблем здоровья семьи и репродукции человека" Способ комплексного лечения дисфункции яичников при применении гормонального контрацептива имплантата "импланона"
CN111057120B (zh) * 2019-12-27 2021-04-27 苏州翔实医药发展有限公司 一种依托孕烯衍生物a及其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1013284B (de) 1956-03-22 1957-08-08 Schering Ag Verfahren zur Einfuehrung der Reste wenig reaktionsfaehiger Carbonsaeuren, insbesondere des ª‰-Cyclopentyl-propionylrestes, in die 17ª‡-staendige Oxygruppe solcher Steroide, die am Kohlenstoffatom 17 neben der Oxygruppe eine Acetylgruppe tragen
GB845442A (en) 1956-03-22 1960-08-24 Schering Ag Manufacture of steroid compounds
GB8313921D0 (en) * 1983-05-19 1983-06-22 World Health Org Contraceptive compositions
DE4227989A1 (de) 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
DE4240806A1 (de) 1992-12-01 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 14alpha,17alpha-Ethanoestra-1,3,5(10)-trien-3,17beta-diol
JPH07101884A (ja) 1993-10-01 1995-04-18 Sanei Gen F F I Inc 水溶性ヘミセルロースを含有する製剤
CZ187796A3 (en) * 1993-12-27 1997-01-15 Akzo Nobel Nv Pharmaceutical preparation
DE19613698A1 (de) 1995-07-17 1997-01-23 Schering Ag Mittel zur transdermalen Applikation enthaltend Ester des 13-Ethyl-17ß-hydroxy-11-methylen-18,19-dinor-17alpha-pregn-4-en-20-yn-3-ons
EP0848620A1 (de) * 1995-07-17 1998-06-24 Schering Aktiengesellschaft Mittel zur transdermalen applikation enthaltend ester des 3-ketodegestrel
WO1999067270A1 (en) 1998-06-19 1999-12-29 Akzo Nobel N.V. Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)
KR100596649B1 (ko) 1998-06-19 2006-07-06 악조 노벨 엔.브이. 테스토스테론 유도체
US6180682B1 (en) * 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters

Also Published As

Publication number Publication date
RU2325910C2 (ru) 2008-06-10
AU2003238081A1 (en) 2003-12-19
HRP20041101A2 (en) 2004-12-31
ZA200410410B (en) 2006-02-22
JP2005532350A (ja) 2005-10-27
NZ536619A (en) 2007-09-28
KR20050009723A (ko) 2005-01-25
AR040130A1 (es) 2005-03-16
CN1692122A (zh) 2005-11-02
MXPA04011797A (es) 2005-03-31
CO5631449A2 (es) 2006-04-28
CA2487722C (en) 2011-07-19
BR0311254A (pt) 2005-03-15
US7323454B2 (en) 2008-01-29
DE60310714D1 (de) 2007-02-08
DE60310714T2 (de) 2007-10-11
TW200403065A (en) 2004-03-01
PT1513861E (pt) 2007-03-30
AU2003238081B2 (en) 2008-09-18
EP1513861A2 (en) 2005-03-16
WO2003102012A9 (en) 2005-01-13
DK1513861T3 (da) 2007-04-10
HK1072609A1 (en) 2005-09-02
ES2277085T3 (es) 2007-07-01
WO2003102012A2 (en) 2003-12-11
UA80126C2 (en) 2007-08-27
RS97604A (en) 2006-10-27
US20050222113A1 (en) 2005-10-06
PL373855A1 (en) 2005-09-19
WO2003102012A3 (en) 2004-04-22
IS2421B (is) 2008-10-15
CA2487722A1 (en) 2003-12-11
RU2004138807A (ru) 2005-05-27
IS7528A (is) 2004-11-15
ATE349458T1 (de) 2007-01-15
JP4716726B2 (ja) 2011-07-06
CN1314701C (zh) 2007-05-09
CN101100480A (zh) 2008-01-09
PE20040068A1 (es) 2004-02-18
EP1513861B1 (en) 2006-12-27
SI1513861T1 (sl) 2007-06-30
IL165087A0 (en) 2005-12-18

Similar Documents

Publication Publication Date Title
NO20044898L (no) Nye etonogestrel estere
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
ATE474617T1 (de) Medizinproduktsysteme
NO20091976L (no) Nye forbindelser
ATE264863T1 (de) 28-epirapaloge
DE60326611D1 (de) N und dergleichen
NO20044597L (no) Kjemiske forbindelser
NO20074807L (no) Fast farmasoytisk doseringsformulering
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
DE602004026113D1 (de) Glp-1-verbindungen
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
WO2003103571A3 (en) VACCINES AGAINST FLAVIVIRUSES
NO20044448L (no) Nye forbindelser
DE60305522D1 (de) Pharmazeutische zusammensetzung enthaltend tenatoprazol und einen entzündungshemmer
ITRM20020305A1 (it) Camptotecine con anello lattonico modificato.
DK1713438T3 (da) Medicinsk sæbe
IS7537A (is) Notkun á nýjum etónógestrel esterum.
ATE414540T1 (de) Impfstoffe gegen allergien
IS7441A (is) Peptíðdeformýlasatálmar
MY137953A (en) New association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent
ITMI20031659A1 (it) Visualizzatore e procedimento di fabbricazione.
DE60232650D1 (de) Peptiddeformylaseinhibitoren
NO20015922L (no) Nye calpainer og anvendelse derav
TW200500012A (en) Novel lactobacillus and use thereof
DE60207384D1 (de) Peptid-deformylase-hemmer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application